CMPX

CMPX Operating Cash Flow (Statement)

-$54.79MTTM · USD

Period ending:

CMPX FY Cash from OperationsUSD
CMPX FY Cash from Operations2019-03-31: -$33.68M2020-03-31: -$31.74M2020-12-31: -$26.80M2021-12-31: -$19.67M2022-12-31: -$34.13M2023-12-31: -$40.62M2024-12-31: -$44.86M2025-12-31: -$49.14M$0.00-$49.14M
2019-03-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CMPX operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 8 observations from Mar 31, 2019 to Dec 31, 2025.

Compass Therapeutics Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-49,143,000
-44,855,000
-40,618,000
-34,125,000
-19,666,000
-26,803,000
-31,741,000
-33,679,000

Compare operating cash flow (statement)

All CMPX financial metrics · CMPX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.